We are live on ! Find out more
MURA

Mural Oncology
MURA

Delisted

MURA was delisted on the 4th of December, 2025.

Back to rankings

123 hedge funds and large institutions have $79.7M invested in Mural Oncology in 2023 Q4 according to their latest regulatory filings, with 123 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

80.7% more ownership

Funds ownership: 0% → 80.7% (+81%)

Holders
123
Holders Change
+123
Holders Change %
–
% of All Funds
1.79%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
123
Increased
–
Reduced
–
Closed
–
Calls
$12K
Puts
–
Net Calls
+$12K
Net Calls Change
+$12K

Top Buyers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$7.98M
2
AC
Armistice Capital
New York
+$6.67M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$6.13M
4
BlackRock
BlackRock
New York
+$4.72M
5
AFA
Alta Fundamental Advisers
New York
+$2.41M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
KAM
26
Krensavage Asset Management
New York
$538K +$365K +90,833 New
BFM
27
Boothbay Fund Management
New York
$534K +$363K +90,166 New
N
28
Nuveen
North Carolina
$531K +$361K +89,683 New
Charles Schwab
29
Charles Schwab
California
$481K +$327K +81,208 New
SC
30
Shay Capital
New York
$447K +$304K +75,543 New
Marshall Wace
31
Marshall Wace
United Kingdom
$444K +$302K +75,039 New
American Century Companies
32
American Century Companies
Missouri
$422K +$287K +71,348 New
PAM
33
Panagora Asset Management
Massachusetts
$378K +$257K +63,924 New
PMEF
34
Point72 Middle East FZE
United Arab Emirates
$369K +$251K +62,314 New
Arrowstreet Capital
35
Arrowstreet Capital
Massachusetts
$305K +$207K +51,559 New
Connor, Clark & Lunn Investment Management (CC&L)
36
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$303K +$206K +51,162 New
Ensign Peak Advisors
37
Ensign Peak Advisors
Utah
$259K +$176K +43,759 New
Fidelity Investments
38
Fidelity Investments
Massachusetts
$251K +$170K +42,398 New
Jane Street
39
Jane Street
New York
$229K +$155K +38,619 New
JP Morgan Chase
40
JP Morgan Chase
New York
$208K +$141K +35,148 New
Swiss National Bank
41
Swiss National Bank
Switzerland
$195K +$132K +32,870 New
Aberdeen Group
42
Aberdeen Group
United Kingdom
$191K +$130K +32,342 New
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$180K +$122K +30,357 New
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$168K +$114K +28,427 New
T. Rowe Price Associates
45
T. Rowe Price Associates
Maryland
$154K +$105K +25,992 New
Barclays
46
Barclays
United Kingdom
$154K +$104K +25,954 New
Qube Research & Technologies (QRT)
47
Qube Research & Technologies (QRT)
United Kingdom
$152K +$103K +25,729 New
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$142K +$96.5K +23,999 New
CCM
49
CAAS Capital Management
New York
$136K +$92.3K +22,954 New
CS
50
Credit Suisse
Switzerland
$135K +$91.5K +22,758 New
1
2
3 4 5

MURA Hedge Fund Activity: Q4 2023 in Review

123 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q4 2023, worth a combined $79.7M.

Buyers outnumbered sellers: 123 funds opened new MURA positions and 0 closed out — a net gain of 123 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Westfield Capital Management, opening a new position worth an estimated $7.98M.

  • 123 institutional investors held Mural Oncology (MURA) as of Q4 2023, up from 0 in Q3 2023.
  • Funds reported $79.7M of Mural Oncology stock for Q4 2023.
  • 123 funds opened new Mural Oncology positions in Q4 2023 and 0 closed out, a net change of +123 holders.
  • The largest Mural Oncology buyer in Q4 2023 was Westfield Capital Management, an estimated $7.98M added.

Based on aggregated 13F filings for Q4 2023.